Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Edvardsen
Henrik Edvardsen, Copenhagen N DK
| Patent application number | Description | Published |
|---|---|---|
| 20100016820 | TOW-COMPONENT SEALANT COMPRISING CROSS-LINKED POLYALKYLENE OXIDE - The present invention relates to a two-component sealant comprising a first part and a second part wherein | 01-21-2010 |
Henrik Edvardsen, Koebenhavn DK
| Patent application number | Description | Published |
|---|---|---|
| 20100168693 | FAECAL MANAGEMENT DEVICE - A faecal management device suitable for attachment directly to the perianal skin between the buttocks of the wearer. The device utilises an optimised adhesive wafer in order to securely attach the device to the skin of the wearer so that the device is maintained in position for the entire period of wear, including circumstances or periods of wear during which the wearer is active, i.e. not bedridden. In addition the faecal management device of the present invention has the ability for easy application of the device. | 07-01-2010 |
Kjell Edvardsen, Flataasen NO
| Patent application number | Description | Published |
|---|---|---|
| 20100307402 | DEVICE FOR CONTROLLING THE POSITION OF AN INSTRUMENT CABLE TOWED IN WATER - A control device ( | 12-09-2010 |
Klaus Edvardsen, Klampenborg DK
| Patent application number | Description | Published |
|---|---|---|
| 20100150936 | PREVENTION OF RASH IN PATIENTS UNDERGOING ANTI-EGFR THERAPY - The invention relates to a method for the treatment of a disease susceptible to anti-EGFR treatment, comprising the step of administering, to a human being in nee thereof, a combination of an anti-EGFR agent and an anti-neutrophil-chemoattracta agent, wherein said anti-neutrophil-chemoattractant agent is administered in a dosage regimen that is sufficient to reduce one or more undesired dermatological side-effects the anti-EGFR agent. In one embodiment, the anti-EGFR agent is an anti-EGF antibody and the anti-neutrophil-chemoattractant agent is an anti-IL-8 antibody. | 06-17-2010 |
| 20110256142 | NOVEL METHODS AND ANTIBODIES FOR TREATING CANCER - The invention relates to novel methods for the treatment of tumors, comprising administration of a bispecific antibody or a combination of two or more non-cross-blocking antibodies that recognize the same target antigen or antigenic complex. In particular, the invention relates to a method for inducing complement-mediated cell killing in the treatment of a tumor, said method comprising combined administration, to a human being in need thereof, of a first antibody and a second antibody, wherein—said first antibody binds EGFR, —said second antibody binds EGFR, —said first and second antibody are non-cross-blocking, and—the dosage regimen is such that CDC is obtained at the tumor site. | 10-20-2011 |
Klaus Edvardsen, Lund SE
| Patent application number | Description | Published |
|---|---|---|
| 20090258937 | Methods for Modulating Tumor Growth and Metastasis - Methods and pharmaceutical compositions for modulating tumor growth or metastasis are provided. | 10-15-2009 |
Per Espen Edvardsen, Fyllingsdalen NO
| Patent application number | Description | Published |
|---|---|---|
| 20100218937 | Seal For A Drill String - Sealing arrangement for dynamic sealing around a drill stem ( | 09-02-2010 |
| 20100236791 | Device And Method For Maintaining Constant Pressure On, And Flow Drill Fluid, In A Drill String - A device is described for maintaining a predominately constant pressure on, and flow of drilling fluid in, a drill string ( | 09-23-2010 |
Thor Edvardsen, Oslo NO
| Patent application number | Description | Published |
|---|---|---|
| 20110263996 | METHODS FOR ESTIMATING THE RISK FOR VENTRICULAR ARRHYTHMIAS IN A SUBJECT - The present invention relates to methods for predicting the risk for ventricular arrhythmias in a subject who has previously suffered a myocardial infarction (MI) or suffers from a primary cardiomyopathy, said method comprising measuring the myocardial mechanical dispersion in said subject and estimating the risk for ventricular arrhythmias based on said measurements. Similar the invention relates to a method for evaluating whether a subject is a candidate for implantable cardioverter-defibrillator (ICD) therapy. | 10-27-2011 |